PCN29 THE COST SAVINGS ASSOCIATED WITH BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BEVACIZUMAB-BASED THERAPY) TREATMENT COMPARED WITH CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CETUXIMAB-BASED THERAPY) IN PATIENTS WITH ADVANCED OR RECURRENT ...
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73266-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)73266-6/fulltext
Section Title :
Section Order :
691
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73266-6&doi=10.1016/S1098-3015(10)73266-6